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Using PCR–denaturing gradient gel electrophoresis, 
we examined 49 fecal samples from healthy volunteers 
and 128 diarrhea specimens to assess the distribution of 
Epsilonproteobacteria that might be routinely overlooked. 
Our results suggest that certain taxa that are not routinely 
examined for could account for a proportion of diarrhea of 
previously unknown etiology.
Acute gastrointestinal illness is a major health concern in industrialized countries. In New Zealand, an 
estimated 4.6 million cases of acute gastrointestinal illness 
occur every year (1). For many known causes of acute 
gastrointestinal illness, conventional methods of diagnosis 
are available; yet, ≈80% of diarrhea cases go undiagnosed 
(1,2). This lack of data concerning causes of diarrhea 
hinders the development of intervention strategies.
The class Epsilonproteobacteria is a distinct, diverse 
bacterial group containing ≈100 taxa (3), including 
Campylobacter jejuni, recognized as the most frequent 
bacterial cause of human gastroenteritis worldwide (4,5). 
Many other epsilonproteobacterial species have been 
associated with diarrhea, but accurate estimates of the 
prevalence and role of individual species and proof of 
a primary pathogenic role have been elusive. Methods 
commonly used for isolating C. jejuni are not well suited 
for many other species, and the complex taxonomy of the 
group makes identifi cation diffi cult (4). Nevertheless, the 
body of evidence supporting a causative role for several taxa 
has grown (5–7). During September 2007–June 2009, we 
examined fecal samples from healthy volunteers and from 
patients with diarrhea in New Zealand by using a PCR–
denaturing gradient gel electrophoresis (DGGE) method 
shown to detect and identify Epsilonproteobacteria (8).
The Study
Healthy volunteers were recruited during 2 separate 
periods in September 2007 and June 2009. The fi rst 
recruitment period (18 specimens) did not specifi cally 
exclude volunteers who had had gastrointestinal 
disturbances in the 10 days before sampling. The second (31 
specimens) were healthy volunteers who had normal bowel 
habit, no diarrheal disease for >6 weeks, no antimicrobial 
drug therapy for >4 weeks, and no medication except 
for asthma inhalers or antihypertensive or contraceptive 
medication. Volunteers defecated into a bottle suspended 
in the lavatory bowl with tissue paper to prevent it falling 
into the water. The Upper South A Regional Ethics 
Committee (Christchurch, New Zealand) and the multi-
ethics committee of the Ministry of Health, New Zealand 
(MEC/08/52/EXP), granted ethics approval for the study.
Diarrhea specimens (submitted without patient 
details during 2008) were distributed among 3 categories, 
as follows. First were 32 samples in which no causal 
agent was found; pathogens were excluded by routine 
examination with conventional diagnostic techniques for 
bacteria, parasites, and norovirus at Southern Community 
Laboratories. Second were 57 samples in which a specifi c 
causal agent was not found; samples were examined at the 
Institute of Environmental Science and Research (ESR, 
Christchurch, New Zealand) reference laboratory by using 
conventional methods for a specifi c pathogen at the request 
of the submitting laboratory. Third were 39 samples in 
which a known gastrointestinal pathogen had been detected 
at ESR.
Samples were refrigerated for 24–48 h before DNA 
extracts were prepared by using the revised protocol 
described in the ZR Fecal DNA Kit (Zymo Research, 
Irvine, CA, USA). Fecal DNA extracts were examined with 
the PCR-DGGE for Epsilonproteobacteria as described 
(8). After visualization of the PCR-amplifi ed product, 
individual DNA bands were excised and then DNA was 
eluted by diffusion into buffer and reexamined by PCR 
to obtain partial 16S rDNA amplicons for sequencing. 
Sequences were edited (primer sequences were removed) 
and subsequently compared with those in GenBank by 
using BLAST (http://blast.ncbi.nlm.nih.gov/Blast.cgi). 
Comparisons were made during April 2011. Assignment 
of sequences to a taxon was based on the E (expect) values 
obtained and on expert opinion of the taxonomic distance 
between the most likely matches obtained. BLAST matches 
yielded E-values ranging from 7.13e-62 to 2.26e-124.
Of 177 samples from the healthy volunteers and patients 
with diarrhea, 159 contained Epsilonproteobacteria, of 
which 20 contained >1 taxa (Table). C. rectus/showae, C. 
sputorum, C. upsaliensis, Helicobacter pullorum, and H. 
pylori/heilmannii/nemestrinae were detected in 11 (8.6%) 
of the 128 diarrhea samples but not in fecal specimens from 
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volunteers. Cryptosporidium spp. also were present in 2 
diarrhea samples in which C. rectus/showae were detected. 
In addition, norovirus was detected in the C. sputorum–
positive sample. C. curvus and C. jejuni/coli were found 
in diarrhea samples examined previously for specifi c 
pathogens only, as well as in 1 and 4 samples, respectively, 
from human volunteers. Sequences of the C. concisus 
complex, C. ureolyticus, C. hominis, and C. gracilis 
occurred frequently in samples from all study participants.
We used χ2 analysis to determine whether the 
proportion of the 32 diarrhea samples subjected to a 
complete pathogen screen differed signifi cantly from 
fecal samples from the second group of 31 volunteers 
in which these organisms were detected. The pathogen 
screen contained C. (Bacteroides) ureolyticus, C. concisus 
complex, C. hominis, or C. gracilis. We found no statistical 
difference between the proportions detected in these 2 
groups of samples.
Conclusions
Although many species belonging to the 
Epsilonproteobacteria have been associated with 
gastrointestinal illness for decades, few are proven primary 
pathogens. By using PCR-DGGE to examine feces from 
healthy volunteers and patients with diarrhea, we aimed 
to indicate which taxa might be present as commensal 
fl ora and which might have a causal role. C. upsaliensis/
helveticus, H. pullorum, H. pylori/heilmannii/nemestrinae 
were all detected in diarrhea specimens but not in specimens 
from healthy volunteers; no other pathogen was found 
in these diarrhea specimens. C. upsaliensis is presumed 
to be pathogenic (7). H. pullorum is poorly studied but 
bears suffi cient similarity to diarrheogenic C. jejuni at the 
molecular–genetic level (9) to support a causative role in 
gastrointestinal disease, at least for some strains. Poultry 
harbor H. pullorum (10), and thus represent a vector for 
foodborne transmission. Use of the PCR-DGGE method (8) 
on domestic drinking and commercial scald water used in 
New Zealand chicken production detected H. pullorum in 
2 of 5 samples tested (data not shown). Although detection 
of the taxa H. pylori/heilmannii/nemestrinae might simply 
represent gastric carriage (the natural environment for 
these species), perhaps gastric disturbances result in 
diarrheal sequalae. Even though C. rectus/showae were 
also detected only in diarrhea samples, 2 specimens also 
harbored Cryptosporidium spp. In addition, norovirus was 
detected in the diarrhea sample in which C. sputorum was 
found.
We detected C. jejuni/coli in 3 samples examined 
for, but not containing, E. coli O157, which indicates that 
some cases of campylobacteriosis go undiagnosed. To our 
surprise, we detected C. jejuni/coli in several fecal samples 
from healthy volunteers. This detection might represent 
asymptomatic carriage of C. jejuni/coli, a phenomenon 
more commonly observed in developing countries where 
repeated exposure during a prolonged period results in 
tolerance (11). The high incidence of infection in New 
Zealand makes this hypothesis credible.
C. concisus was the most frequently encountered 
species in this study and occurred in participants from both 
groups. Strains identifi ed as C. concisus with conventional 
methods might belong to genetically distinct but 
phenotypically indistinguishable genomospecies differing 
in their pathogenic potential (12). The PCR-DGGE used 
here cannot differentiate C. concisus genomospecies; thus 
strains detected in volunteers and strains found in diarrhea 
samples might represent distinct genomospecies with 
different pathogenic potentials.
We detected C. hominis, C. gracilis, and C. ureolyticus 
in fecal samples of healthy volunteers and patients with 
diarrhea. C. hominis has long been considered a commensal 
(13). A molecular study found C. ureolyticus in 83 (23.8%) 
of 349 Campylobacter spp.–positive diarrhea samples, but 
no healthy controls were examined (14). Our data suggest 
these species are unlikely causes of diarrhea.
Our results indicate that certain Epsilonproteobacteria 
that are not routinely examined for account for a proportion 
of diarrhea cases of previously unknown etiology. PCR-
DGGE is a useful tool to study the prevalence and 
distribution of these bacteria. C. concisus genomospecies 
are frequently detected in human disease (5,15; this study); 
elucidation of their pathogenicity should be considered a 
public health research issue.
 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 18, No. 3, March 2012 511
Table. Prevalence and distribution of Epsilonproteobacteria taxa 
in fecal samples from 49 healthy volunteers and 128 persons 
with diarrhea, New Zealand* 
Taxa SCL ESR? ESR+ Vol 
Campylobacter jejuni/coli 
complex
0 3 0 4 
C. ureolyticus 3 10 1 12 
C. concisus 17 27 16 26 
C. curvus 0 1 0 1 
C. gracilis 4 10 4 3 
C. hominis 4 6 1 8 
C. rectus/showae 2 1 2 0 
C. sputorum 0 0 1 0 
Helicobacter sp. 1 0 0 0 
C. upsaliensis/helveticus 0 2 0 0 
H. pullorum 0 2 0 0 
No Epsiloproteobacterium 6 3 8 1 
*Detected by PCR–denaturing gradient gel electrophoresis. SCL, samples 
examined by Southern Community Laboratories (Christchurch, New 
Zealand) found negative for all common pathogens; ESR–, diarrhea 
samples screened for specific pathogens by the Institute of Environmental 
Science and Research (Christchurch) at the request of the submitting 
laboratory and found negative; ESR+, diarrhea samples screened for 
specific pathogens by the Institute of Environmental Science and 
Research at the request of the submitting laboratory and found positive; 
vol, samples from volunteers with no known recent history of 
gastrointestinal illness. Specific pathogens found in ESR+ samples 
included Cryptosporidium spp., Giardia spp., norovirus, Bacillus cereus,
toxigenic Staphylococcus aureus, and toxigenic Clostridium perfringens.
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